Strategic Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-343
| Closed | -$218K | – | 246 |
|
|
2025
Q1 | $218K | Sell |
343
-42
| -11% | -$26.7K | 0.02% | 231 |
|
|
2024
Q4 | $275K | Buy |
385
+31
| +9% | +$22.1K | 0.03% | 214 |
|
|
2024
Q3 | $373K | Sell |
354
-3
| -0.8% | -$3.16K | 0.04% | 203 |
|
|
2024
Q2 | $376K | Sell |
357
-29
| -8% | -$30.5K | 0.05% | 195 |
|
|
2024
Q1 | $372K | Buy |
386
+21
| +6% | +$20.2K | 0.05% | 195 |
|
|
2023
Q4 | $321K | Buy |
365
+1
| +0.3% | +$878 | 0.05% | 198 |
|
|
2023
Q3 | $300K | Buy |
364
+9
| +3% | +$7.41K | 0.05% | 201 |
|
|
2023
Q2 | $255K | Buy |
355
+36
| +11% | +$25.9K | 0.04% | 175 |
|
|
2023
Q1 | $262K | Buy |
+319
| New | +$262K | 0.05% | 214 |
|
|
2020
Q3 | – | Sell |
-398
| Closed | -$248K | – | 185 |
|
|
2020
Q2 | $248K | Buy |
+398
| New | +$248K | 0.09% | 153 |
|